Similar to our results, Coffelt and colleagues reported that ovarian tumor-derived leucine, leucine-37 recruits MSCs to the tumor microenvironment and stimulated MSCs secreted larger amounts of pro-angiogenic factors including IL-1 receptor antagonist, IL-6, IL-10 and VEGF to support angiogenesis [50]. This evidence concerns the gene IL10 and ovarian neoplasm.